Article

A next generation CRISPR diagnostic tool to survey drug resistance in Human African Trypanosomiasis

2024-09-17

Abstract excerpt

The WHO aims to eliminate the gambiense form of human African trypanosomiasis (HAT) by 2030. With the decline of reported cases, maintaining efficient epidemiological surveillance is essential, including the emergence of drug-resistant strains. We have developed new highly specific diagnostic tools using Specific High-Sensitivity Reporter Enzymatic UnLOCKing (SHERLOCK) technology for monitoring the presence of dru...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: c76dd11f-b910-5228-962d-3817fc8ab6d7
DOI: 10.1101/2024.09.15.24313552

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

A next generation CRISPR diagnostic tool to survey drug resistance in Human African TrypanosomiasisDOI 10.1101/2024.09.15.24313552Read

A CRISPR-based diagnostic tool to survey drug resistance in human African trypanosomiasis.Semantic proximity Read

SHERLOCK4HAT: A CRISPR-based tool kit for diagnosis of Human African TrypanosomiasisSemantic proximity Read

A novel CRISPR-based malaria diagnostic capable of <i>Plasmodium</i> detection, speciation, and drug-resistance genotypingSemantic proximity Read

Ultrasensitive CRISPR-based diagnostic for field-applicable detection of Plasmodium species in symptomatic and asymptomatic malariaSemantic proximity Read

A novel CRISPR-based malaria diagnostic capable of Plasmodium detection, species differentiation, and drug-resistance genotyping.Semantic proximity Read

Acoziborole resistance associated mutations in trypanosome CPSF3Semantic proximity Read

An expanded method for malaria parasite genetic surveillance using targeted nanopore sequencingSemantic proximity Read

Clinical and veterinary trypanocidal benzoxaboroles target CPSF3Semantic proximity Read

Advancing artemisinin resistance monitoring using a high sensitivity ddPCR assay for Pfkelch13 mutation detection in Asia.Semantic proximity Read

Potential Opportunities and Challenges of Deploying Next Generation Sequencing and CRISPR-Cas Systems to Support Diagnostics and Surveillance Towards Malaria Control and Elimination in AfricaSemantic proximity Read

The current drug discovery landscape for trypanosomiasis and leishmaniasis: Challenges and strategies to identify drug targetsSemantic proximity Read

Dual CRISPR/Cas13a Cascade Strand Displacement-Triggered Transcription for Point-of-Care Detection of Plasmodium in Asymptomatic MalariaSemantic proximity Read